title: [Correction of indigestion in chronic biliary pancreatitis].
abstract: Chronic pancreatitis (CP) is one of the most urgent and investigated problems in gastroenterology. Despite the variety of the spectrum of etiologic, pathogenetic and provoking factors for CP, one of the leading causes of disease pathology is pathology of biliary tract. A key element in the treatment of CP is a correction of the digestive system, with biliary pancreatitis feature that distinguishes it from other forms of pancreatitis, is a combination of exocrine pancreatic insufficiency with chronic biliary insufficiency. The variety of biochemical and immunological effects of ursodeoxycholic acid (UDCA) can treat it with biliary pancreatitis as the drug of etiological, pathogenetic and substitution therapy. UDCA (Ursosan) in combination with modern mini-microspheroidal polyfermental drugs significantly improves the clinical efficacy of the correction of the digestive system in biliary pancreatitis.
authors.forename: D I
authors.initials: DI
authors.lastname: Trukhan
authors.forename: L V
authors.initials: LV
authors.lastname: Tarasova
mesh_terms: D001652:Bile Ducts / Q000378:metabolism / Q000503:physiopathology; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D004415:Dyspepsia / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D050500:Pancreatitis, Chronic / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
chemical_list: D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid